Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
AstraZeneca PLC (LON:AZN) Insider Tony Mok Buys 1,500 Shares
astrazeneca non-executive director buys company shares By Investing.com
Howe & Rusling Inc. Sells 29,784 Shares of AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca (NASDAQ:AZN) Upgraded at UBS Group | MarketBeat
Jennison Associates LLC Sells 2,059,108 Shares of AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca shares trade higher on UBS Upgrade By Investing.com
Leerink Partnrs Predicts Increased Earnings for AstraZeneca
AstraZeneca Is No Longer a Sell for Any Analyst as UBS Upgrades
AstraZeneca PLC (NASDAQ:AZN) Stock Holdings Boosted by Pathstone Holdings LLC
Leerink Partnrs Reduces Earnings Estimates for AstraZeneca
Can AstraZeneca stock recover? UBS points to regulatory support despite challenges By Investing.com
New Millennium Group LLC Sells 28,749 Shares of AstraZeneca PLC (NASDAQ:AZN)
Prospera Financial Services Inc Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Leerink Partnrs Cuts Earnings Estimates for AstraZeneca
SouthState Corp Acquires 1,025 Shares of AstraZeneca PLC (NASDAQ:AZN)
Jones Trading raises Monopar Therapeutics target to $37 By Investing.com
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Sumitomo Mitsui Trust Group Inc.
Analysts Set AstraZeneca PLC (LON:AZN) PT at £104.12
Stocks in news: Waaree Energies, GMR Infra, AstraZeneca, Indus Towers, Ashoka Buildcon & ITI
CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC - November 19, 2024 - Zacks.com
Daiichi Sankyo, Astrazeneca submit new BLA for Trop2 lung cancer ADC | BioWorld
Regulatory actions for Nov. 19, 2024 | BioWorld
Lunit Collaborates With AstraZeneca To Develop AI-powered Digital Pathology Solutions | Markets Insider
AstraZeneca to launch Breztri Aerosphere for COPD treatment following DCGI approval, ET LegalWorld
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC | The Manila Times
Is AstraZeneca PLC (AZN) the Best Immunotherapy Stock to Buy Now?
EMA committee recommends approval of AstraZeneca’s lung-cancer drug ‘Tagrisso’
Is AstraZeneca PLC (AZN) A Cheap NASDAQ Stock To Invest In Now?
Quell Therapeutics Achieves Milestone for Type 1 Diabetes CAR-Treg Cell Therapy Program | The Manila Times
Political Shifts: The Pulse of Pharma Stock Volatility
Trump’s Nomination of RFK Jr. to Lead HHS a Potential Industry Headwind | Morningstar
Astrazeneca (AZN) is a Top-Ranked Growth Stock: Should You Buy? - November 18, 2024 - Zacks.com
Astrazeneca exercises option for type 1 diabetes Treg cell therapy program with Quell | BioWorld
Other news to note for November 18, 2024 | BioWorld
Pascal Soriot Purchases 20,000 Shares of AstraZeneca PLC (LON:AZN) Stock
Natixis Advisors LLC Boosts Holdings in AstraZeneca PLC (NASDAQ:AZN)
AIM ImmunoTech Inc. (AMEX:AIM) Q3 2024 Earnings Call Transcript - Insider Monkey
AstraZeneca PLC (NASDAQ:AZN) Sees Large Increase in Short Interest
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Koa Wealth Management LLC
Trump anti-vax health appointment wipes £7bn from AstraZeneca and GSK By Proactive Investors
Insider Buying: AstraZeneca PLC (LON:AZN) Insider Buys 20,000 Shares of Stock
Sustainability consultancy eyes growth following £500k backing | TheBusinessDesk.com
AstraZeneca (NASDAQ:AZN) Releases Earnings Results, Beats Estimates By $0.03 EPS
FTSE 100 subdued as pharma stocks weigh By Reuters
Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback - November 15, 2024 - Zacks.com
AstraZeneca (NASDAQ:AZN) Announces Earnings Results
AstraZeneca (NASDAQ:AZN) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS
AstraZeneca slumps as Q2 PAT slides 27% YoY to Rs 38 cr | Capital Market News - Business Standard
Earnings call: Innate Pharma Q3 2024 results highlight oncology pipeline By Investing.com
LBT Innovations Rebrands and Expands in Pharma Market
Kepler Capital Remains a Hold on AstraZeneca (AZN)
MQS Management LLC Has $832,000 Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
Absci Corporation (NASDAQ:ABSI) Q3 2024 Earnings Call Transcript
AstraZeneca PLC (NASDAQ:AZN) Q3 2024 Earnings Call Transcript
Healthy Returns: AstraZeneca boosts U.S. investment on confidence in economy
AstraZeneca's (AZN) Robust Growth in China Despite Leadership Challenges
AstraZeneca Pharma India Q2FY25 results: Net profit falls 27% to Rs 38 cr | Company Results - Business Standard
AstraZeneca Investment: AstraZeneca announces $3.5 billion plan to expand U.S. R&D and manufacturing operations, ETPharma
AstraZeneca Q2 net profit declines 10%, revenue up 31%
CWA Asset Management Group LLC Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (AZN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
AstraZeneca Reports Strong Growth in Q3 2024
Datopotamab Deruxtecan New BLA Submitted for Accelerated Approval in the US for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results By Investing.com
Trending: AstraZeneca Expands Its Investment Plan in the U.S. | Morningstar
AstraZeneca Talks Up US Growth as China Problems Worsen
AstraZeneca lifts outlook as it doubles down on US growth
AstraZeneca invests $3.5 billion in US expansion By Investing.com
Wuxi's iCampus signs strategic cooperation with HK's health center and AstraZeneca - Chinadaily.com.cn
AstraZeneca PLC (NASDAQ:AZN) Given Consensus Recommendation of “Buy” by Analysts
AstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
Astra Invests $3.5 Billion in US as Cancer Drug Lifts Sales
AstraZeneca raises expectation for next year profits after Q3 performance | World News - Business Standard
City round-up; Franchise Brands; BAE Systems; Coral Products; Astra Zeneca; Convatec; McBride | TheBusinessDesk.com
AstraZeneca's 9M and Q3 2024 results By Investing.com
AstraZeneca To Invest $3.5 Bln In US To Expand R&D And Manufacturing | Markets Insider
AstraZeneca Raises Outlook on Earnings, Sales Beat | Morningstar
AstraZeneca Q3 Net Income Rises; Upgrades 2024 Guidance
CREDIT UPDATE: AstraZeneca (AZN: A2 pos/A+/Au pos): 3Q24
AstraZeneca: Koselugo Phase III Trial Meets Primary Goal In Adults With Neurofibromatosis Type 1
AstraZeneca Q3 earnings beat estimates, raises full-year outlook By Investing.com
European markets fall as mining stocks slide; Bayer shares at 20-year lows; Mediobanca down 8%
AstraZeneca raises 2024 outlook on strong Q3 By Investing.com
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat By Reuters
AstraZeneca investing $3.5bn in R & D and manufacturing in the US
AstraZeneca Beats on Q3 Earnings, Ups 2024 View, to Invest $3.5B in US - November 12, 2024 - Zacks.com
Datopotamab Deruxtecan New BLA Submitted for Accelerated Approval in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer By Investing.com
AstraZeneca News | Markets Insider
Biliary Tract Cancer Market Size in the 7MM was ~USD 1000 million, is expected to grow by 2034, estimated DelveInsight
GDS Wealth Management Sells 448 Shares of AstraZeneca PLC (NASDAQ:AZN)
Buckingham Capital Management Inc. Sells 10,133 Shares of AstraZeneca PLC (NASDAQ:AZN)
Earnings To Watch: AstraZeneca PLC (OSTO:AZN) Reports Q3 2024 Result
Atria Investments Inc Buys 9,431 Shares of AstraZeneca PLC (NASDAQ:AZN)
ANGLE plc ("the Company") DNA ANALYSIS OF PARSORTIX-ENRICHE
Latest news
MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K
Nasdaq futures decline, Nvidia shares dip following the earnings report
Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024